Japan· JP-3999045M1028
ミガーラスタット塩酸塩
A migalastat product containing ミガーラスタット塩酸塩, registered in Japan by アミカス・セラピューティクス, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Migalastat is registered in 16 of 19 countries.
Countries holding a registration under ATC A16AX14 (migalastat), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 11 of them publish a price we can compare per daily dose
Migalastat · ATC A16AX14
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of migalastat costs, country by country.
Normalised to the WHO defined daily dose (61.5 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Migalastat · price per daily dose (61.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$793.74
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ミガーラスタット塩酸塩
- Manufacturer
- アミカス・セラピューティクス
- Country
- Japan (JP)
- ATC code
- A16AX14
- ATC class
- Migalastat
- Defined daily dose
- 61.5 mg, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1 interaction on record for migalastat.
Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Migalastat · interactions on record
1 record
- 1 moderate
Most severe, free to view
- Agalsidase betaA16AB04moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under A16AX14
Migalastat, as other registers publish it.
- NorwayGalafoldAmicus Therapeutics Europe Limited
- FinlandGalafoldAmicus Therapeutics Europe Limited
- PolandGalafoldAmicus Therapeutics Europe Limited
- United StatesGalafoldAmicus Therapeutics US, LLC
- DenmarkGalafoldAmicus Therapeutics Europe Ltd
- SwitzerlandGalafold
- IcelandGalafoldAmicus Therapeutics Europe Limited*
- CanadaGALAFOLDAMICUS THERAPEUTICS CANADA INC.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e7af2627-1a15-41a3-b325-47cb3d38b0c4 GET /v1/drugs/e7af2627-1a15-41a3-b325-47cb3d38b0c4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１２３ｍｇ１カプセル",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "3999045M1028",
"category": "内用薬",
"price_yen": 145304,
"generic_name": "ミガーラスタット塩酸塩",
"product_name_jp": null,
"therapeutic_class": "3999",
"transitional_expiry": null
}See everything about migalastat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.